Document Detail

Prevention of haemodialysis-induced hypotension by biofeedback control of ultrafiltration and infusion.
MedLine Citation:
PMID:  11239038     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Haemodialysis-induced hypotension is still a severe complication in spite of all the progress in haemodialysis treatment. Because of its multifactorial causes, haemodialysis-induced hypotension cannot be reliably prevented by conventional ultrafiltration and sodium profiling in open-loop systems, as they are unable to adapt themselves to actual decreases in blood pressure. METHODS: A blood-pressure-guided closed-loop system, for prevention of haemodialysis-induced hypotension by biofeedback-driven computer control of both ultrafiltration and saline infusion was clinically tested in 237 treatments of seven patients prone to hypotension. As medical knowledge on multifactorial causes of hypotension is characterized by a lack in deterministic knowledge, fuzzy logic and linguistic variables were used to involve clinical experience on hypotension phenomena in terms of fuzzy knowledge. Biofeedback control is based on frequent measurements of blood pressure at 5 min intervals. Blood pressure behaviour is described by linguistic variables and fuzzy sets. Adaptive rule bases were used for the simultaneous fuzzy control of both the ultrafiltration and infusion of hypertonic saline (20% NaCl). Proper adaptation of control features to patient's conditions was provided by the critical borderline pressure, which was set by the physician individually at the beginning of each treatment. During the initial and medium phases of the sessions, ultrafiltration rates up to 150% of the average rates were applied as long as decreases in blood pressure could be compensated by saline infusion. The surplus of ultrafiltrate volume was used for blood pressure stabilization in the final phase in most instances by low ultrafiltration rates. RESULTS: The advantages of biofeedback-controlled haemodialysis were demonstrated by both decreasing the frequency of hypotonic episodes and by increasing or maintaining constant levels of systolic blood pressure during the final phase in 88% of treatments. As saline infusion was applied mainly in the initial and medium phases, blood sodium levels were not significantly higher at the end of the sessions, and interdialytic weight gain was not elevated. CONCLUSION: The application of fuzzy logic in the blood-pressure-guided biofeedback control of ultrafiltration and sodium infusion during haemodialysis is able to minimize haemodialysis-induced hypotension.
R Schmidt; O Roeher; H Hickstein; S Korth
Related Documents :
7297318 - Sodium intake, blood pressure and red cell sodium efflux.
3696348 - Vegetarian diet and blood pressure.
1665068 - The pressor effect of sodium-volume expansion is calcium mediated.
17203778 - Enhancement of cytotoxic activity of sodium fluoride against human periodontal ligament...
6715228 - Hemodynamics before and after conversion of atrial fibrillation to normal sinus rhythm ...
16723728 - Optimal strategy for cardiopulmonary resuscitation with continuous chest compression.
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  16     ISSN:  0931-0509     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-03-12     Completed Date:  2001-07-19     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  595-603     Citation Subset:  IM    
Department of Internal Medicine, University of Rostock, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biofeedback, Psychology*
Blood Pressure / drug effects
Fuzzy Logic
Hypotension / prevention & control*
Renal Dialysis / adverse effects*
Saline Solution, Hypertonic / therapeutic use*
Sodium / blood
Reg. No./Substance:
0/Saline Solution, Hypertonic; 7440-23-5/Sodium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Haemodialysis with the biocompatible high permeability AN-69 membrane does not alter plasma insulin-...
Next Document:  Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag syste...